Brianna Cagle

Brianna Cagle has a diverse range of work experience in research and scientific roles. Brianna currently works as an Assistant Research Scientist at Perspective Therapeutics, where they started in March 2023. Prior to this, they held a similar position at Viewpoint Molecular Targeting, Inc. starting in January 2022.

Their educational background includes being a PhD candidate in the Pharmaceutical Sciences and Experimental Therapeutics department at the University of Iowa. Brianna conducted research in the laboratory of Dr. Jon Doorn, focusing on understanding the etiology of Parkinson's disease using cellular models. Their time at the University of Iowa lasted from August 2016 to January 2022.

In 2020, Brianna worked as a Research Intern at Integrated DNA Technologies. During this internship, they contributed to enzyme development research, specifically in aptamer development to modulate temperature-specific enzyme activity. This position lasted from July 2020 to October 2020.

Prior to their graduate studies, Brianna gained experience as a QC Chemist at Trinity Biotech from May 2015 to July 2016. This position provided their with HPLC experience, testing various components for quality.

Brianna also worked as an Undergraduate Researcher at UMKC from August 2014 to May 2015, and as a Summer Intern at the University of Kansas Medical Center in June 2014 to August 2014. In the latter role, they focused on pharmacological and toxicological research related to cytochrome P450, specifically CYP3A7 in the fetal liver, using fluorescent substrates to develop a high-throughput drug inhibition assay.

Overall, Brianna Cagle's work experience showcases their dedication to research in various scientific fields, including pharmaceutical sciences, molecular targeting, enzyme development, and pharmacology.

Brianna Cagle completed their Associate of Science (A.S.) degree in Science and Mathematics at Northwest Missouri State University from 2010 to 2012. Brianna then pursued their Bachelor of Science (B.S.) degree in Chemistry at the University of Missouri-Kansas City from 2012 to 2015. Following that, they attended the University of Iowa where they obtained their PhD degree from 2016 to 2021. The field of study for their PhD is not specified.